$TORC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adicet Bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Adicet Bio, Inc.. Get notifications about new insider transactions in Adicet Bio, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 08 2021 | TORC | Adicet Bio, Inc. | Galimi Francesco | SVP & Chief Medical ... | Option Exercise | M | 5.97 | 6,983 | 41,689 | 121,441 | |
Jun 08 2021 | TORC | Adicet Bio, Inc. | Galimi Francesco | SVP & Chief Medical ... | Buy | M | 5.97 | 6,983 | 41,689 | 6,983 | 0 to 7 K |
Jun 08 2021 | TORC | Adicet Bio, Inc. | Galimi Francesco | SVP & Chief Medical ... | Option Exercise | M | 5.97 | 6,983 | 41,689 | 121,441 | |
Jun 08 2021 | TORC | Adicet Bio, Inc. | Galimi Francesco | SVP & Chief Medical ... | Buy | M | 5.97 | 6,983 | 41,689 | 6,983 | 0 to 7 K |
May 21 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President & CEO | Sell | S | 13.73 | 733 | 10,062 | 107,800 | 108.5 K to 107.8 K (-0.68 %) |
May 21 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President & CEO | Sell | S | 13.42 | 8,249 | 110,728 | 108,533 | 116.8 K to 108.5 K (-7.06 %) |
May 21 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President & CEO | Sell | S | 13.73 | 612 | 8,401 | 89,809 | 90.4 K to 89.8 K (-0.68 %) |
May 21 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President & CEO | Sell | S | 13.42 | 6,872 | 92,244 | 90,421 | 97.3 K to 90.4 K (-7.06 %) |
May 20 2021 | TORC | Adicet Bio, Inc. | Jakobovits Aya | Director | Sell | S | 14.23 | 900 | 12,805 | 217,806 | 218.7 K to 217.8 K (-0.41 %) |
May 20 2021 | TORC | Adicet Bio, Inc. | Jakobovits Aya | Director | Sell | S | 14.23 | 892 | 12,692 | 217,807 | 218.7 K to 217.8 K (-0.41 %) |
May 20 2021 | TORC | Adicet Bio, Inc. | Jakobovits Aya | Director | Sell | S | 14.06 | 3,100 | 43,573 | 218,706 | 221.8 K to 218.7 K (-1.40 %) |
May 20 2021 | TORC | Adicet Bio, Inc. | Jakobovits Aya | Director | Sell | S | 14.05 | 3,108 | 43,676 | 218,699 | 221.8 K to 218.7 K (-1.40 %) |
May 14 2021 | TORC | Adicet Bio, Inc. | Jakobovits Aya | Director | Sell | S | 13.24 | 5,000 | 66,205 | 221,806 | 226.8 K to 221.8 K (-2.20 %) |
May 14 2021 | TORC | Adicet Bio, Inc. | Jakobovits Aya | Director | Sell | S | 13.23 | 5,000 | 66,128 | 221,807 | 226.8 K to 221.8 K (-2.20 %) |
May 07 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President & CEO | Sell | S | 14.70 | 3,670 | 53,951 | 116,782 | 120.5 K to 116.8 K (-3.05 %) |
May 07 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President & CEO | Sell | S | 13.90 | 5,312 | 73,814 | 120,452 | 125.8 K to 120.5 K (-4.22 %) |
May 07 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President & CEO | Sell | S | 14.70 | 3,058 | 44,954 | 97,293 | 100.4 K to 97.3 K (-3.05 %) |
May 07 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President & CEO | Sell | S | 13.90 | 4,426 | 61,502 | 100,351 | 104.8 K to 100.4 K (-4.22 %) |
May 04 2021 | TORC | Adicet Bio, Inc. | Sinclair Andrew | Director | Option Exercise | A | 15.93 | 8,172 | 130,180 | 8,172 | |
May 04 2021 | TORC | Adicet Bio, Inc. | Sinclair Andrew | Director | Option Exercise | A | 15.93 | 18,500 | 294,705 | 18,500 | |
May 04 2021 | TORC | Adicet Bio, Inc. | Sanna Bastiano | Director | Option Exercise | A | 15.93 | 1,172 | 18,670 | 1,172 | |
May 04 2021 | TORC | Adicet Bio, Inc. | Sanna Bastiano | Director | Option Exercise | A | 15.93 | 18,500 | 294,705 | 18,500 | |
May 04 2021 | TORC | Adicet Bio, Inc. | Jakobovits Aya | Director | Option Exercise | A | 15.93 | 18,500 | 294,705 | 18,500 | |
May 04 2021 | TORC | Adicet Bio, Inc. | GORDON CARL L | Director | Option Exercise | A | 15.93 | 18,500 | 294,705 | 18,500 | |
May 04 2021 | TORC | Adicet Bio, Inc. | DUBIN STEVE | Director | Option Exercise | A | 15.93 | 18,500 | 294,705 | 18,500 | |
May 04 2021 | TORC | Adicet Bio, Inc. | Chodakewitz Jeffrey | Director | Option Exercise | A | 15.93 | 18,500 | 294,705 | 18,500 | |
Apr 22 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President and CEO | Sell | S | 12.01 | 7,484 | 89,846 | 104,777 | 112.3 K to 104.8 K (-6.67 %) |
Apr 22 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President and CEO | Sell | S | 12.01 | 8,982 | 107,830 | 125,764 | 134.7 K to 125.8 K (-6.67 %) |
Apr 08 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President and CEO | Sell | S | 13.04 | 7,484 | 97,584 | 112,261 | 119.7 K to 112.3 K (-6.25 %) |
Apr 08 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President and CEO | Sell | S | 13.04 | 8,982 | 117,116 | 134,746 | 143.7 K to 134.7 K (-6.25 %) |
Apr 01 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President and CEO | Sell | S | 13.22 | 4,500 | 59,490 | 119,745 | 124.2 K to 119.7 K (-3.62 %) |
Apr 01 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President and CEO | Sell | S | 13.22 | 5,400 | 71,388 | 143,728 | 149.1 K to 143.7 K (-3.62 %) |
Apr 01 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President and CEO | Sell | S | 12.30 | 2,984 | 36,703 | 124,245 | 127.2 K to 124.2 K (-2.35 %) |
Apr 01 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President and CEO | Sell | S | 12.30 | 3,582 | 44,059 | 149,128 | 152.7 K to 149.1 K (-2.35 %) |
Mar 18 2021 | TORC | Adicet Bio, Inc. | Klickstein Lloyd | Chief Innovation Of ... | Payment of Exercise | F | 0.00 | 4,957 | 0 | 11,931 | 16.9 K to 11.9 K (-29.35 %) |
Mar 18 2021 | TORC | Adicet Bio, Inc. | Klickstein Lloyd | Chief Innovation Of ... | Grant | A | 0.00 | 16,888 | 0 | 16,888 | 33.8 K to 16.9 K (-50.00 %) |
Mar 18 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President and CEO | Sell | S | 15.66 | 2,089 | 32,714 | 127,229 | 129.3 K to 127.2 K (-1.62 %) |
Mar 18 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President and CEO | Sell | S | 15.07 | 2,508 | 37,796 | 152,710 | 155.2 K to 152.7 K (-1.62 %) |
Mar 18 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President and CEO | Sell | S | 15.66 | 5,395 | 84,486 | 129,318 | 134.7 K to 129.3 K (-4.00 %) |
Mar 18 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President and CEO | Sell | S | 15.07 | 6,474 | 97,563 | 155,218 | 161.7 K to 155.2 K (-4.00 %) |
Mar 04 2021 | TORC | Adicet Bio, Inc. | Sinclair Andrew | Director | Option Exercise | A | 15.75 | 28,828 | 454,041 | 28,828 | |
Feb 18 2021 | TORC | Adicet Bio, Inc. | Chimovits Erez | Director | Grant | A | 13.00 | 104,050 | 1,352,650 | 396,657 | 292.6 K to 396.7 K (+35.56 %) |
Feb 18 2021 | TORC | Adicet Bio, Inc. | Chimovits Erez | Director | Grant | A | 13.00 | 420,299 | 5,463,887 | 5,243,259 | 4.8 M to 5.2 M (+8.71 %) |
Feb 18 2021 | TORC | Adicet Bio, Inc. | GORDON CARL L | Director | Grant | A | 13.00 | 104,050 | 1,352,650 | 396,657 | 292.6 K to 396.7 K (+35.56 %) |
Feb 18 2021 | TORC | Adicet Bio, Inc. | GORDON CARL L | Director | Grant | A | 13.00 | 420,299 | 5,463,887 | 5,243,259 | 4.8 M to 5.2 M (+8.71 %) |
Feb 18 2021 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Grant | A | 13.00 | 104,050 | 1,352,650 | 396,657 | 292.6 K to 396.7 K (+35.56 %) |
Feb 18 2021 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Grant | A | 13.00 | 420,299 | 5,463,887 | 5,243,259 | 4.8 M to 5.2 M (+8.71 %) |
Feb 17 2021 | TORC | Adicet Bio, Inc. | ABBOT STEWART | See Remarks | Option Exercise | A | 16.82 | 106,900 | 1,798,058 | 106,900 | |
Feb 17 2021 | TORC | Adicet Bio, Inc. | Klickstein Lloyd | Chief Innovation Of ... | Option Exercise | A | 16.82 | 41,100 | 691,302 | 41,100 | |
Feb 17 2021 | TORC | Adicet Bio, Inc. | Harvey Brian Nicholas | Chief Financial Off ... | Option Exercise | A | 16.82 | 28,200 | 474,324 | 28,200 | |
Feb 17 2021 | TORC | Adicet Bio, Inc. | Healey Don | Chief Technology Of ... | Option Exercise | A | 16.82 | 30,400 | 511,328 | 30,400 | |
Feb 17 2021 | TORC | Adicet Bio, Inc. | Krehlik Carrie | Chief Human Resourc ... | Option Exercise | A | 16.82 | 11,200 | 188,384 | 11,200 | |
Feb 17 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President and CEO | Option Exercise | A | 16.82 | 421,600 | 7,091,312 | 421,600 | |
Feb 17 2021 | TORC | Adicet Bio, Inc. | Galimi Francesco | See Remarks | Option Exercise | A | 16.82 | 28,400 | 477,688 | 28,400 | |
Jan 15 2021 | TORC | Adicet Bio, Inc. | Klickstein Lloyd | Chief Innovation Of ... | Option Exercise | A | 13.27 | 80,000 | 1,061,600 | 80,000 | |
Jan 15 2021 | TORC | Adicet Bio, Inc. | Healey Don | Chief Technology Of ... | Option Exercise | A | 13.27 | 70,000 | 928,900 | 70,000 | |
Jan 15 2021 | TORC | Adicet Bio, Inc. | Krehlik Carrie | Chief Human Resourc ... | Option Exercise | A | 13.27 | 40,000 | 530,800 | 40,000 | |
Jan 15 2021 | TORC | Adicet Bio, Inc. | Galimi Francesco | See Remarks | Option Exercise | A | 13.27 | 80,000 | 1,061,600 | 80,000 | |
Jan 15 2021 | TORC | Adicet Bio, Inc. | Schor Chen | President and CEO | Option Exercise | A | 13.27 | 240,000 | 3,184,800 | 240,000 | |
Jan 15 2021 | TORC | Adicet Bio, Inc. | ABBOT STEWART | See Remarks | Option Exercise | A | 13.27 | 80,000 | 1,061,600 | 80,000 | |
Jan 15 2021 | TORC | Adicet Bio, Inc. | Harvey Brian Nicholas | Chief Financial Off ... | Option Exercise | A | 13.27 | 90,000 | 1,194,300 | 90,000 | |
Oct 29 2020 | TORC | Adicet Bio, Inc. | Healey Don | Chief Technology Of ... | Option Exercise | A | 12.23 | 166,605 | 2,037,579 | 166,605 | |
Oct 27 2020 | TORC | Adicet Bio, Inc. | Schor Chen | President and CEO | Payment of Exercise | F | 0.00 | 8,649 | 0 | 72,499 | 81.1 K to 72.5 K (-10.66 %) |
Sep 17 2020 | TORC | Adicet Bio, Inc. | DUBIN STEVE | Director | Option Exercise | A | 16.11 | 30,000 | 483,300 | 30,000 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Jakobovits Aya | Director | Option Exercise | A | 16.11 | 30,000 | 483,300 | 30,000 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Jakobovits Aya | Director | Grant | A | 0.00 | 77,500 | 0 | 77,500 | 0 to 77.5 K |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Jakobovits Aya | Director | Grant | A | 0.00 | 77,500 | 0 | 77,500 | 0 to 77.5 K |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Jakobovits Aya | Director | Grant | A | 0.00 | 135,799 | 0 | 135,799 | 0 to 135.8 K |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Jakobovits Aya | Director | Grant | A | 0.00 | 627,812 | 0 | 627,812 | 0 to 627.8 K |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Schindel Yair Chaim | Director | Option Exercise | A | 16.11 | 30,000 | 483,300 | 30,000 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Schindel Yair Chaim | Director | Grant | A | 0.00 | 1,104,460 | 0 | 1,104,460 | 0 to 1.1 M |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Klickstein Lloyd | Chief Innovation Of ... | Option Exercise | A | 16.11 | 193,027 | 3,109,665 | 193,027 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Schor Chen | President and CEO | Option Exercise | A | 16.11 | 872,111 | 14,049,708 | 872,111 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Chimovits Erez | Director | Option Exercise | A | 16.11 | 30,000 | 483,300 | 30,000 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Chimovits Erez | Director | Grant | A | 0.00 | 292,607 | 0 | 292,607 | 0 to 292.6 K |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Chimovits Erez | Director | Grant | A | 0.00 | 902,885 | 0 | 902,855 | -30 to 902.9 K (-3,009,616.67 %) |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ABBOT STEWART | See Remarks | Option Exercise | A | 16.11 | 63,751 | 1,027,029 | 63,751 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ABBOT STEWART | See Remarks | Option Exercise | A | 5.97 | 57,151 | 341,191 | 57,151 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ABBOT STEWART | See Remarks | Option Exercise | A | 2.26 | 84,791 | 191,628 | 84,791 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Chodakewitz Jeffrey | Director | Option Exercise | A | 16.11 | 30,000 | 483,300 | 30,000 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Krehlik Carrie | Chief Human Resourc ... | Option Exercise | A | 16.11 | 40,391 | 650,699 | 40,391 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Krehlik Carrie | Chief Human Resourc ... | Option Exercise | A | 5.97 | 15,450 | 92,237 | 15,450 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Krehlik Carrie | Chief Human Resourc ... | Option Exercise | A | 2.26 | 18,600 | 42,036 | 18,600 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Galimi Francesco | Chief Medical Offic ... | Option Exercise | A | 16.11 | 77,269 | 1,244,804 | 77,269 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | Galimi Francesco | Chief Medical Offic ... | Option Exercise | A | 5.97 | 128,424 | 766,691 | 128,424 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 16.11 | 30,000 | 483,300 | 30,000 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 16.11 | 30,000 | 483,300 | 30,000 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Grant | A | 0.00 | 292,607 | 0 | 292,607 | 0 to 292.6 K |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Grant | A | 0.00 | 902,885 | 0 | 902,855 | -30 to 902.9 K (-3,009,616.67 %) |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Grant | A | 0.00 | 4,822,960 | 0 | 4,822,960 | 0 to 4.8 M |
Sep 17 2020 | TORC | Adicet Bio, Inc. | GORDON CARL L | Director | Option Exercise | A | 16.11 | 30,000 | 483,300 | 30,000 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | GORDON CARL L | Director | Grant | A | 0.00 | 292,607 | 0 | 292,607 | 0 to 292.6 K |
Sep 17 2020 | TORC | Adicet Bio, Inc. | GORDON CARL L | Director | Grant | A | 0.00 | 902,885 | 0 | 902,855 | -30 to 902.9 K (-3,009,616.67 %) |
Sep 17 2020 | TORC | Adicet Bio, Inc. | GORDON CARL L | Director | Grant | A | 0.00 | 4,822,960 | 0 | 4,822,960 | 0 to 4.8 M |
Jun 05 2020 | TORC | resTORbio, Inc. | Grissinger Michael | Director | Option Exercise | A | 2.23 | 14,414 | 32,143 | 14,414 | |
Jun 05 2020 | TORC | resTORbio, Inc. | FONTEYNE PAUL R. | Director | Option Exercise | A | 2.23 | 14,414 | 32,143 | 14,414 | |
Jun 05 2020 | TORC | resTORbio, Inc. | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 2.23 | 14,414 | 32,143 | 14,414 | |
Jun 05 2020 | TORC | resTORbio, Inc. | Sullivan Lynne Marie | Director | Option Exercise | A | 2.23 | 14,414 | 32,143 | 14,414 | |
Jun 05 2020 | TORC | resTORbio, Inc. | Steinberg David Adam | Director | Option Exercise | A | 2.23 | 14,414 | 32,143 | 14,414 | |
Dec 19 2019 | TORC | resTORbio, Inc. | PureTech Health LLC | 10% Owner | Sell | S | 1.20 | 6,161,531 | 7,393,837 | 2,119,696 | 8.3 M to 2.1 M (-74.40 %) |
Dec 17 2019 | TORC | resTORbio, Inc. | PureTech Health LLC | 10% Owner | Sell | S | 1.24 | 205,763 | 255,805 | 8,281,227 | 8.5 M to 8.3 M (-2.42 %) |
Dec 12 2019 | TORC | resTORbio, Inc. | PureTech Health LLC | 10% Owner | Sell | S | 1.25 | 385,884 | 482,316 | 8,486,990 | 8.9 M to 8.5 M (-4.35 %) |
Dec 12 2019 | TORC | resTORbio, Inc. | PureTech Health LLC | 10% Owner | Sell | S | 1.25 | 59,921 | 74,901 | 8,872,874 | 8.9 M to 8.9 M (-0.67 %) |
Dec 12 2019 | TORC | resTORbio, Inc. | PureTech Health LLC | 10% Owner | Sell | S | 1.26 | 336,561 | 423,663 | 8,932,795 | 9.3 M to 8.9 M (-3.63 %) |
Dec 06 2019 | TORC | resTORbio, Inc. | Mannick Joan | Chief Medical Offic ... | Option Exercise | A | 1.27 | 88,667 | 112,607 | 88,667 | |
Dec 06 2019 | TORC | resTORbio, Inc. | Mannick Joan | Chief Medical Offic ... | Grant | A | 0.00 | 118,222 | 0 | 1,404,585 | 1.3 M to 1.4 M (+9.19 %) |
Dec 06 2019 | TORC | resTORbio, Inc. | MCCABE JOHN J | Vice President, Fin ... | Option Exercise | A | 1.27 | 16,400 | 20,828 | 16,400 | |
Dec 06 2019 | TORC | resTORbio, Inc. | MCCABE JOHN J | Vice President, Fin ... | Grant | A | 0.00 | 12,867 | 0 | 12,867 | 0 to 12.9 K |
Dec 06 2019 | TORC | resTORbio, Inc. | Klickstein Lloyd | Chief Scientific Of ... | Option Exercise | A | 1.27 | 88,667 | 112,607 | 88,667 | |
Dec 06 2019 | TORC | resTORbio, Inc. | Klickstein Lloyd | Chief Scientific Of ... | Grant | A | 0.00 | 118,222 | 0 | 118,222 | 0 to 118.2 K |
Dec 06 2019 | TORC | resTORbio, Inc. | Schor Chen | President and CEO | Option Exercise | A | 1.27 | 258,000 | 327,660 | 258,000 | |
Dec 06 2019 | TORC | resTORbio, Inc. | Schor Chen | President and CEO | Grant | A | 0.00 | 344,000 | 0 | 669,000 | 325 K to 669 K (+105.85 %) |
Nov 19 2019 | TORC | resTORbio, Inc. | PureTech Health LLC | 10% Owner | Sell | S | 1.25 | 531,040 | 661,941 | 9,269,356 | 9.8 M to 9.3 M (-5.42 %) |
May 15 2019 | TORC | resTORbio, Inc. | Klickstein Lloyd | Chief Scientific Of ... | Option Exercise | A | 8.08 | 295,000 | 2,383,600 | 295,000 | |
May 09 2019 | TORC | resTORbio, Inc. | Sullivan Lynne Marie | Director | Option Exercise | A | 7.99 | 14,414 | 115,168 | 14,414 | |
May 09 2019 | TORC | resTORbio, Inc. | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 7.99 | 14,414 | 115,168 | 14,414 | |
May 09 2019 | TORC | resTORbio, Inc. | Grissinger Michael | Director | Option Exercise | A | 7.99 | 14,414 | 115,168 | 14,414 | |
May 09 2019 | TORC | resTORbio, Inc. | Chodakewitz Jeffrey | Director | Option Exercise | A | 7.99 | 14,414 | 115,168 | 14,414 | |
May 09 2019 | TORC | resTORbio, Inc. | FONTEYNE PAUL R. | Director | Option Exercise | A | 7.99 | 14,414 | 115,168 | 14,414 | |
May 09 2019 | TORC | resTORbio, Inc. | Steinberg David Adam | Director | Option Exercise | A | 7.99 | 14,414 | 115,168 | 14,414 | |
Feb 28 2019 | TORC | resTORbio, Inc. | Mannick Joan | Chief Medical Offic ... | Option Exercise | A | 8.53 | 93,000 | 793,290 | 93,000 | |
Feb 28 2019 | TORC | resTORbio, Inc. | Schor Chen | President and CEO | Option Exercise | A | 8.53 | 214,000 | 1,825,420 | 214,000 | |
Feb 28 2019 | TORC | resTORbio, Inc. | Manning Meredith | Chief Commercial Of ... | Option Exercise | A | 8.53 | 26,000 | 221,780 | 26,000 | |
Feb 28 2019 | TORC | resTORbio, Inc. | MCCABE JOHN J | Vice President, Fin ... | Option Exercise | A | 8.53 | 24,600 | 209,838 | 24,600 | |
Dec 17 2018 | TORC | resTORbio, Inc. | Schor Chen | See Remarks | Gift | G | 0.00 | 6,000 | 0 | 325,000 | 331 K to 325 K (-1.81 %) |
Dec 17 2018 | TORC | resTORbio, Inc. | Schor Chen | See Remarks | Gift | G | 0.00 | 6,000 | 0 | 325,000 | 331 K to 325 K (-1.81 %) |
Dec 17 2018 | TORC | resTORbio, Inc. | Schor Chen | See Remarks | Gift | G | 0.00 | 25,000 | 0 | 943,000 | 968 K to 943 K (-2.58 %) |
Dec 17 2018 | TORC | resTORbio, Inc. | Schor Chen | See Remarks | Gift | G | 0.00 | 25,000 | 0 | 943,000 | 968 K to 943 K (-2.58 %) |
Dec 17 2018 | TORC | resTORbio, Inc. | Schor Chen | See Remarks | Gift | G | 0.00 | 643,000 | 0 | 943,000 | 1.6 M to 943 K (-40.54 %) |
Dec 17 2018 | TORC | resTORbio, Inc. | Schor Chen | See Remarks | Gift | G | 0.00 | 643,000 | 0 | 943,000 | 1.6 M to 943 K (-40.54 %) |
Dec 17 2018 | TORC | resTORbio, Inc. | Schor Chen | See Remarks | Gift | G | 0.00 | 25,000 | 0 | 331,000 | 356 K to 331 K (-7.02 %) |
Dec 17 2018 | TORC | resTORbio, Inc. | Schor Chen | See Remarks | Gift | G | 0.00 | 25,000 | 0 | 331,000 | 356 K to 331 K (-7.02 %) |
Dec 17 2018 | TORC | resTORbio, Inc. | Schor Chen | See Remarks | Gift | G | 0.00 | 593,363 | 0 | 356,000 | 949.4 K to 356 K (-62.50 %) |
Dec 17 2018 | TORC | resTORbio, Inc. | Schor Chen | See Remarks | Gift | G | 0.00 | 593,363 | 0 | 356,000 | 949.4 K to 356 K (-62.50 %) |
Dec 17 2018 | TORC | resTORbio, Inc. | Schor Chen | See Remarks | Gift | G | 0.00 | 943,000 | 0 | 949,363 | 1.9 M to 949.4 K (-49.83 %) |
Dec 17 2018 | TORC | resTORbio, Inc. | Schor Chen | See Remarks | Gift | G | 0.00 | 943,000 | 0 | 949,363 | 1.9 M to 949.4 K (-49.83 %) |
Dec 17 2018 | TORC | resTORbio, Inc. | Mannick Joan | Chief Medical Offic ... | Gift | G | 0.00 | 600,000 | 0 | 600,000 | 0 to 600 K |
Dec 17 2018 | TORC | resTORbio, Inc. | Mannick Joan | Chief Medical Offic ... | Gift | G | 0.00 | 600,000 | 0 | 600,000 | 0 to 600 K |
Dec 17 2018 | TORC | resTORbio, Inc. | Mannick Joan | Chief Medical Offic ... | Gift | G | 0.00 | 600,000 | 0 | 1,286,363 | 1.9 M to 1.3 M (-31.81 %) |
Dec 17 2018 | TORC | resTORbio, Inc. | Mannick Joan | Chief Medical Offic ... | Gift | G | 0.00 | 600,000 | 0 | 1,286,363 | 1.9 M to 1.3 M (-31.81 %) |
Nov 06 2018 | TORC | resTORbio, Inc. | Grissinger Michael | Director | Option Exercise | A | 11.82 | 28,828 | 340,747 | 28,828 | |
Sep 18 2018 | TORC | resTORbio, Inc. | Manning Meredith | Chief Commercial Of ... | Option Exercise | A | 13.94 | 175,000 | 2,439,500 | 175,000 | |
Aug 15 2018 | TORC | resTORbio, Inc. | Chodakewitz Jeffrey | Director | Option Exercise | A | 10.42 | 28,828 | 300,388 | 28,828 | |
Apr 17 2018 | TORC | resTORbio, Inc. | Schor Chen | President and CEO | Buy | P | 8.95 | 2,000 | 17,907 | 1,892,363 | 1.9 M to 1.9 M (+0.11 %) |
Apr 12 2018 | TORC | resTORbio, Inc. | Schor Chen | President and CEO | Buy | P | 9.36 | 2,000 | 18,724 | 1,890,363 | 1.9 M to 1.9 M (+0.11 %) |
Apr 11 2018 | TORC | resTORbio, Inc. | Schor Chen | President and CEO | Buy | P | 8.46 | 2,000 | 16,915 | 1,888,363 | 1.9 M to 1.9 M (+0.11 %) |
Mar 14 2018 | TORC | resTORbio, Inc. | MCCABE JOHN J | Vice President, Fin ... | Option Exercise | A | 15.45 | 4,603 | 71,116 | 4,603 | |
Jan 30 2018 | TORC | resTORbio, Inc. | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 1,871,569 | 0 | 0 | |
Jan 30 2018 | TORC | resTORbio, Inc. | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 2,425,482 | 0 | 0 | |
Jan 30 2018 | TORC | resTORbio, Inc. | SILVERSTEIN JONATHAN | Director | Buy | P | 15.00 | 533,333 | 7,999,995 | 4,830,387 | 4.3 M to 4.8 M (+12.41 %) |